Company intelligence / Profile preview

Asahi Kasei Pharma

Chiyoda-ku, Tokyo, Japanasahikasei-pharma.co.jp ↗
Ownership
Public · 3407
Employees
~1700
Development stage
Other
01

Overview

Asahi Kasei Pharma is a global specialty pharma with commercial and late-stage programs in immunology, nephrology, transplantation, critical care, pain, and musculoskeletal disorders, pursuing growth via proprietary R&D, licensing, and recent acquisitions in rare renal and transplantation fields.

Therapeutic areas
ImmunologyEndocrinologyRheumatologyNephrologyMen's HealthInfectious DiseasesGastroenterologyHematologyNeurology
Modalities
Small moleculeRecombinant proteinMonoclonal antibodyPeptidesPEGylated peptideBiologic
Industry
Biotech
02

Drug pipeline

8 assets

thrombomodulin alfa

4

7 more assets in the full pipeline.

03

Partnerships

Ironwood Pharmaceuticals (apraglutide licensing)Array BioPharma (subsidiary of Pfizer, licensor for AK1830)SBI Biotech (licensee for AK1910)Basilea Pharmaceutica (Cresemba, antifungal licensing/marketing)Swedish Orphan Biovitrum (DOPTELET, EMPAVELI distribution)Sanofi (KEVZARA distribution, RA)
04

Financials

Market cap
$12.6B
Total revenue
$19.4B
Enterprise value
$17.5B

Beyond the preview

Go deeper on Asahi Kasei Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asahi Kasei Pharma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call